FDA advisory members are meeting Sept. 11-12 to vote on whether phenylephrine should be reclassified as ineffective amid data suggesting the common ingredient in over-the-counter cold medicines does not relieve symptoms when taken orally.
Read the full post on Becker's Hospital Review - Healthcare News
